Conference Program
 
CYCLIC NUCLEOTIDE PHOSPHODIESTERASES

June 23-28, 2002
Mount Holyoke College
South Hadley, MA

Chairs:
Sharron Francis & Eva Degerman

Vice Chairs:
Mary S. Barnette & Donald H. Maurice

The next Gordon Research Conference on Cyclic Nucleotide Phosphodiesterases will be held June 23-28, 2002 at Mt. Holyoke College in South Hadley, Massachusetts. Mt. Holyoke is a small liberal arts college located in a college town in the beautiful Berkshire Mountains of western Massachusetts. This is a relatively new site for Gordon Conferences, but facilities are considered to be excellent. Both the lecture hall and lodging facilities are reportedly modern and comfortable.

The Conferences site can be easily reached by flying into Boston, Hartford, or New York. Many leisure activities are available for participants. Hiking in the nearby Berkshire Mountains is easily accessible. Other activities include tennis (indoor and outdoor), canoeing, "championship" golf course (on campus), an arboretum, swimming, racquetball, basketball, volleyball, squash, softball, indoor and outdoor tracks, and a well-equipped fitness center.

 

CONTRIBUTORS

 
  • Abbott Bioresearch Center
  • Almirall Prodesfarma S.A.
  • Bayer
  • Byk Gulden Pharmaceuticals
  • Celgene Corporation
  • Cell Pathways, Inc.
  • GlaxoSmithKline, Philadelphia, USA
  • GlaxoSmithKline, Research Triangle Park, USA
  • Kyorin Pharmaceutical Co., Ltd.
  • Memory Pharmaceuticals
  • Merck Frosst Canada
  • Merck Research Laboratories
  • Otsuka Maryland Research Institute
  • Pfizer Central Research USA (Groton)
  • Pfizer Central Research UK (England)
  • R.W. Johnson Pharmaceutical Research Institute
  • Schering Plough Research Institute
  • Suntory Biomedical Research, Ltd.
  • Tanabe Seiyaku Co. Ltd.

Sunday, June 23, 2002
2:00 pm - 9:00 pmArrival and check-in
6:00 pmDinner
Session 1.New Technologies for Studies of Second Messenger Signaling
Discussion Leaders: E. Degerman (Univ. of Lund) & S. Francis (Vanderbilt University)
7:30-8:00 Opening Remarks
8:00-8:30 Natalie Ahn University of Colorado at Boulder, Boulder, CO
Analysis of regulated protein dynamics by deuterium exchange mass spectrometry
8:30-9:00 Jeffrey Karpen University of Colorado School of Medicine, Denver, CO
Resolution of cAMP signals in three-dimensional microdomains using novel, real-time sensors.
9:00-9:30 Wolfgang Dostmann University of Vermont, Burlington, VT
Cygnets: the dynamics of intracellular cGMP revealed by genetically encoded fluorescent indicators
9:45-10:45 pmWelcome Reception
Monday, June 24, 2002
7:30-8:30 Breakfast
8:45Conference Photo
Session 2.Cyclic Nucleotides & Regulation of Energy Metabolism
Discussion Leaders: J. Corbin (Vanderbilt University) & M. Houslay (Univ. of Glasgow)
9:00-9:30 Sven Enerbäck Goteborg University, Goteborg, SWEDEN
FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia and diet induced insulin resistance
9:30-10:00 Vince Manganiello National Heart and Lung Institute, Bethesda, MD.
Characterization of PDE3B KO mice.
10:00-10:30 Hideichi Makino Ehime University School of Medicine, Ehime, Japan
Identification of a PDE3B interacting protein using the yeast two-hybrid system
10:30-11:00Break
11:00-11:30 Tamar Michaeli Albert Einstein School of Medicine, New York, NY
PDEs and regulation of insulin secretion and action
11:30-12:00 Allen Zhao University of Pittsburgh School of Medicine, Pittsburgh, PA
Leptin, PDE3B, and regulation of body weight.
12:00-12:15 Eva Degerman (Short Talk) University of Lund, Lund, SWEDEN
Role of PDE3B in the regulation of energy metabolism.
12:15-12:30 Hanguan Liu (Short talk) National Heart and Lung Institute, Bethesda, MD
Characterization of the PDE3B promotor.
12:30 pmLunch
1:30 pm - 4:30 pmFree Time
4:30 pm - 6:00 pmPoster Session I
6:00 pmDinner
Session 3.GAFs and Cyclic nucleotide-binding domains
Discussion Leaders: N. Artemyev (Univ. of Iowa) & R. Cote (Univ. of New Hampshire)
7:30-8:00 L. Aravind National Center for Biotechnology Information, NIH, Bethesda, MD
Evolutionary history and diversity of cNMP cyclases, phosphodiesterases and associated small molecule binding domains.
8:00-8:30 Joe Beavo University of Washington, Seatttle, WA
PDE2 GAF/cGMP-binding site structure: How good a model for other GAF domains?
8:30-9:00 Joachim Schultz University of Tuebingen. Tubingen, Germany
A GAF-domain operated cAMP switch: adenylyl cyclase from Anabaena
9:00-9:30 Rick Cote University of New Hampshire, Durham NH
Allosteric interactions between catalytic and inhibitory subunits of PDE6 mediated by its GAF domains.
9:30-9:45 Gary Kruh (Short talk) Fox Chase Cancer Center, Philadelphia, PA
Cyclic nucleotide efflux pumps
Tuesday, June 25, 2002
7:30-8:30 Breakfast
Session 4.Cyclic Nucleotides & PDEs: Proliferation, Apoptosis, & Differentiation
Discussion Leaders: M. Conti (Stanford University) & C. Lugnier (University of Strasbourg)
9:00-9:30 Leonard Forte University of Missouri School of Medicine, Columbia MO
Gene expression in colon tumors: guanylin and uroguanylin, receptor-guanylate cyclase and cyclic GMP signaling molecules.
9:30-10:00 Joe Thompson Cell Pathways, Inc., Horsham, PA
SAANDS induce apoptosis via cGMP-mediated mechanisms.
10:00-10:30 Tom Lincoln University of Alabama at Birmingham, Birmingham, AL
Expression of PKG-I in smooth muscle cells: implications in vascular disease.
10:30-11:00Break
11:00-11:30 Claire Lugnier University of Strasbourg, Illkirch, FRANCE
PDEs as potential targets in angiogenesis.
11:30-11:45 Dietrich Dettmer (Short talk) University of Leipzig, Leipzig, GERMANY
Behavior of PDE2 and PDE3 during transformation of rat hepatic stellate cells to myofibroblast-like cells
11:45-12:00 Douglas Tilley (short talk) Queen's University, Kingston, ON, Canada
"Vascular smooth muscle PDE3 and PDE4 activities and levels are regulated by cAMP levels."
12:00-12:15 Hermann Tenor (short talk) Byk Gulden, Konstanz, Germany
" PDE isoenzyme families in osteoarthritis chondrocytes-functional importance of PDE4."
12:15-12:30 Adam Lerner (short talk) Boston Medical Center, Boston, MA
Caspase 9 plays a key role in rolipram-induced apoptosis in primary chronic lymphocytic leukemia cells
12:30 pmLunch
1:30 pm - 4:30 pmFree Time
4:30 pm - 6:00 pmPoster Session I (continued)
6:00 pmDinner
Session 5.Selective Expression of PDEs: Regulation & Function
Discussion Leaders: C. Jin (Stanford University) & D. Dettmer (Univ. of Leipzig)
7:30-8:00 Marco Conti , Stanford University Medical Center, Stanford, CA
Structure and function of different PDE4 isoforms.
8:00-8:30 Don Maurice, Queens University at Kingston, Kingston, Ontario, CANADA
The impact of vascular smooth muscle cell phenotype on phosphodiesterase expression: Impact on regulated cell function.
8:30-9:00 Carolyn Smith , DesignWrite, Princeton, NJ
Regulation of cAMP PDE3 and cGMP PDE5 genes in cardiovascular injury (heart failure and hypertension).
9:00-9:30 Ching Lin , University of California, San Francisco
Human PDE5A gene expression and regulation.
9:30-9:45 Chen Yan (Short talk) University of Rochester, Rochester, NY
Regulation of PDE1A gene expression in vascular smooth muscle cells.
Wednesday, June 26, 2002
7:30-8:30 Breakfast
Session 6. Compartmentalization of Cyclic Nucleotides & Their Intracellular Targets
Discussion Leaders: D. Maurice (Queen's University) & C. Smith (DesignWrite)
9:00-9:30 Laurence Brunton University of California-San Diego, La Jolla CA
Compartmentation of cyclic nucleotide signaling in cardiac cells
9:30-10:00 Rodolphe Fischmeister Universite de Paris-Sud, Paris. France
Contribution of different PDE subtypes to cAMP compartmentation in cardiac myocytes
10:00-10:15 Manuela Zaccolo (Short Talk) University of Padua, Padua, ITALY
cAMP microdomains in heart cells.
10:15-10:45 Break
10:45-11:15 Miles Houslay University of Glasgow, Glasgow, SCOTLAND
Intracellular targeting of PDE4 isoforms
11:15-11:45 Kjetil Tasken University of Oslo, Oslo, NORWAY
PKA-PDE signalling units
11:45-12:00 Jun Kotera (short talk) Tanabe Seiyaku Company, Toda, Saitama, JAPAN
Subcellular localization of phosphodiesterase 10A variants
12:00-12:15Matthew Movsesian (short talk) University of Utah, Salt Lake City, UT
Intracellular compartmentation of PDE3 activity and effects of cAMP and cGMP hydrolysis in cardiac and vascular myocytes
12:15-12:30Wilma van Staveren Maastricht University, Maastricht, The Netherlands
Characterization of the cellular localization of cGMP-hydrolyzing PDEs in the rat hippocampus and related structures
12:30 pmLunch
1:30 pm - 4:30 pmFree Time
4:30 pm - 6:00 pmPoster Session II
6:00 pmDinner
Session 7.Pharmacological Targeting of Cyclic Nucleotide Signaling Pathways
Discussion Leaders: M. Barnette (GlaxoSmithKline) & R. Colman (Temple Univ.)
7:30-8:00Natalie Mount Pfizer Global Research and Development, Sandwich, ENGLAND
New therapeutic opportunities for PDE5 inhibitors.
8:00-8:30 Jun-ichi Kambayashi Otsuka Maryland Research Institute, Rockville, MD
Current progress in clinical and pre-clinical research on cilostazol
8:30-9:00 Erwin Bischoff Bayer-AG
Physiological effects of pharmacologic cGMP elevation.
9:00-9:30 Zheng Huang Merck Frosst, Pointe-Claire-Dorval, CANADA
Mechanistic insights into PDE4 catalyzed cAMP hydrolysis and implications to inhibitor design.
9:30-9:45Peter Schafer (short talk) Celgene Corporation, Warren, NJ
"CC-110004: a novel PDE4 inhibitor with an improved therapeutic index in a lung neutrophilia model."
Thursday, June 27, 2002
7:30-8:30 Breakfast
Session 8.Insights into Structure & Function of PDEs
Discussion Leaders: J. Beavo (University of Washington) & J. Thompson (Cell Pathways, Inc.)
9:00-9:30 Hengming Ke University of North Carolina at Chapel Hill, Chapel Hill, NC
Crystal structure of the PDE4-rolipramcomplex provides insight into the binding and the inhibitor selectivity.
9:30-10:00 Robert Colman Temple University School of Medicine, Philadelphia, PA
PDE3A: Active and inhibitory sites as revealed by mutagenesis, affinity labeling, and molecular modeling.
10:00-10:30 Nikolai Artemyev University of Iowa School of Medicine, Iowa City IA
Structural determinants of PDE6 function
10:30-11:00 Break
11:00-11:30 Ted Wensel Baylor College of Medicine, Houston, TX
Regulation of PDE6 in rod and cone photoreceptors.
11:30-12:00 Jackie Corbin/Sharron Francis Vanderbilt University School of Medicine, Nashville, TN
Allosteric and catalytic sites of PDE5
12:00-12:15 Kenji Omori (Short talk) Tanabe Seiyaku Company, Toda, Saitama, JAPAN
Comparison of characteristics of PDE8 family
12:15-12:30Wito Richter (short talk) Stanford University, Stanford, CA
Involvement of upstream conserved regions in the dimerization of the cAMP-specific PDE4
12:30 pmLunch
1:30 pm - 4:30 pmFree Time
4:30 pm - 6:00 pmPoster Session II (continued)
6:00 pmDinner
Session 9. Selected PDEs: Specificity in Catalysis, Regulation & Function
Discussion Leaders: V. Manganiello (National Institutes of Health) & T. Michaeli (Albert Einstein)
7:30-8:00 Business Session
8:00-8:30 Akio Yamazaki Wayne State University School of Medicine, Detroit, MI
Turnoff of GTP-activated PDE6 withouth GTP hydrolysis: role of cyclin-dependent protein kinase 5.
8:30-9:00Doris Koesling Ruhr-Universitat Bochum, Bochum, GERMANY
A new regulatory mechanism within NO/cGMP signalling
9:00-9:15 Karnam Murthy (Short Talk) Medical College of Virginia, Richmond, VA
Regulation of PDE5 and soluble guanylate cyclase by cGMP-dependent protein kinase in smooth muscle
9:15-9:30 Kelley Bentley Univ. of Michigan, Ann Arbor, MI
Increases in PDE2 phosphorylation by an associated NGF-stimulated kinase
Friday, June 28, 2002
7:30 am - 8:30 amBreakfast
9:00 am Departure

Last Updated: May 4, 2006